Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 60

1.

A 1.5-Year Longitudinal Study of Social Activity in Patients With Schizophrenia.

Ohi K, Sumiyoshi C, Fujino H, Yasuda Y, Yamamori H, Fujimoto M, Sumiyoshi T, Hashimoto R.

Front Psychiatry. 2019 Aug 9;10:567. doi: 10.3389/fpsyt.2019.00567. eCollection 2019.

2.

Eye-movement characteristics of schizophrenia and their association with cortical thickness.

Morita K, Miura K, Fujimoto M, Yamamori H, Yasuda Y, Kudo N, Azechi H, Okada N, Koshiyama D, Shiino T, Fukunaga M, Watanabe Y, Ikeda M, Kasai K, Hashimoto R.

Psychiatry Clin Neurosci. 2019 Aug;73(8):508-509. doi: 10.1111/pcn.12865. Epub 2019 Jun 13. No abstract available.

PMID:
31102322
3.

Eye movement abnormalities and their association with cognitive impairments in schizophrenia.

Morita K, Miura K, Fujimoto M, Yamamori H, Yasuda Y, Kudo N, Azechi H, Okada N, Koshiyama D, Ikeda M, Kasai K, Hashimoto R.

Schizophr Res. 2019 Jul;209:255-262. doi: 10.1016/j.schres.2018.12.051. Epub 2019 Jan 17.

PMID:
30661730
4.

Frequency of mental disorders among chronic pain patients with or without fibromyalgia in Japan.

Miki K, Nakae A, Shi K, Yasuda Y, Yamamori H, Fujimoto M, Ikeda M, Shibata M, Yukioka M, Hashimoto R.

Neuropsychopharmacol Rep. 2018 Dec;38(4):167-174. doi: 10.1002/npr2.12025. Epub 2018 Aug 11.

5.

Genetic Overlap between General Cognitive Function and Schizophrenia: A Review of Cognitive GWASs.

Ohi K, Sumiyoshi C, Fujino H, Yasuda Y, Yamamori H, Fujimoto M, Shiino T, Sumiyoshi T, Hashimoto R.

Int J Mol Sci. 2018 Nov 30;19(12). pii: E3822. doi: 10.3390/ijms19123822. Review.

6.

Predicting work outcome in patients with schizophrenia: Influence of IQ decline.

Sumiyoshi C, Fujino H, Yamamori H, Kudo N, Azechi H, Fujimoto M, Yasuda Y, Ohi K, Sumiyoshi T, Hashimoto R.

Schizophr Res. 2018 Nov;201:172-179. doi: 10.1016/j.schres.2018.05.042. Epub 2018 Jul 4.

PMID:
30473032
7.

Genome-wide Association Analysis of Eye Movement Dysfunction in Schizophrenia.

Kikuchi M, Miura K, Morita K, Yamamori H, Fujimoto M, Ikeda M, Yasuda Y, Nakaya A, Hashimoto R.

Sci Rep. 2018 Aug 17;8(1):12347. doi: 10.1038/s41598-018-30646-9.

8.

Abnormalities of eye movement are associated with work hours in schizophrenia.

Morita K, Miura K, Fujimoto M, Shishido E, Shiino T, Takahashi J, Yamamori H, Yasuda Y, Kudo N, Hirano Y, Koshiyama D, Okada N, Ikeda M, Onitsuka T, Ozaki N, Kasai K, Hashimoto R.

Schizophr Res. 2018 Dec;202:420-422. doi: 10.1016/j.schres.2018.06.064. Epub 2018 Jul 13.

PMID:
30017461
9.

Role of frontal white matter and corpus callosum on social function in schizophrenia.

Koshiyama D, Fukunaga M, Okada N, Morita K, Nemoto K, Yamashita F, Yamamori H, Yasuda Y, Fujimoto M, Kelly S, Jahanshad N, Kudo N, Azechi H, Watanabe Y, Donohoe G, Thompson PM, Kasai K, Hashimoto R.

Schizophr Res. 2018 Dec;202:180-187. doi: 10.1016/j.schres.2018.07.009. Epub 2018 Jul 10.

PMID:
30005932
10.

Semantic Memory Organization in Japanese Patients With Schizophrenia Examined With Category Fluency.

Sumiyoshi C, Fujino H, Sumiyoshi T, Yasuda Y, Yamamori H, Fujimoto M, Hashimoto R.

Front Psychiatry. 2018 Mar 21;9:87. doi: 10.3389/fpsyt.2018.00087. eCollection 2018.

11.

Plasma Levels of Soluble Tumor Necrosis Factor Receptor 2 (sTNFR2) Are Associated with Hippocampal Volume and Cognitive Performance in Patients with Schizophrenia.

Kudo N, Yamamori H, Ishima T, Nemoto K, Yasuda Y, Fujimoto M, Azechi H, Niitsu T, Numata S, Ikeda M, Iyo M, Ohmori T, Fukunaga M, Watanabe Y, Hashimoto K, Hashimoto R.

Int J Neuropsychopharmacol. 2018 Jul 1;21(7):631-639. doi: 10.1093/ijnp/pyy013.

12.

Role of subcortical structures on cognitive and social function in schizophrenia.

Koshiyama D, Fukunaga M, Okada N, Yamashita F, Yamamori H, Yasuda Y, Fujimoto M, Ohi K, Fujino H, Watanabe Y, Kasai K, Hashimoto R.

Sci Rep. 2018 Jan 19;8(1):1183. doi: 10.1038/s41598-017-18950-2.

13.

Subcortical association with memory performance in schizophrenia: a structural magnetic resonance imaging study.

Koshiyama D, Fukunaga M, Okada N, Yamashita F, Yamamori H, Yasuda Y, Fujimoto M, Ohi K, Fujino H, Watanabe Y, Kasai K, Hashimoto R.

Transl Psychiatry. 2018 Jan 10;8(1):20. doi: 10.1038/s41398-017-0069-3.

14.

A Brief Assessment of Intelligence Decline in Schizophrenia As Represented by the Difference between Current and Premorbid Intellectual Quotient.

Ohi K, Sumiyoshi C, Fujino H, Yasuda Y, Yamamori H, Fujimoto M, Sumiyoshi T, Hashimoto R.

Front Psychiatry. 2017 Dec 22;8:293. doi: 10.3389/fpsyt.2017.00293. eCollection 2017. Review.

15.

The effect of duration of illness and antipsychotics on subcortical volumes in schizophrenia: Analysis of 778 subjects.

Hashimoto N, Ito YM, Okada N, Yamamori H, Yasuda Y, Fujimoto M, Kudo N, Takemura A, Son S, Narita H, Yamamoto M, Tha KK, Katsuki A, Ohi K, Yamashita F, Koike S, Takahashi T, Nemoto K, Fukunaga M, Onitsuka T, Watanabe Y, Yamasue H, Suzuki M, Kasai K, Kusumi I, Hashimoto R; COCORO.

Neuroimage Clin. 2017 Nov 8;17:563-569. doi: 10.1016/j.nicl.2017.11.004. eCollection 2018.

16.

Altered sulcogyral patterns of orbitofrontal cortex in a large cohort of patients with schizophrenia.

Isomura S, Hashimoto R, Nakamura M, Hirano Y, Yamashita F, Jimbo S, Yamamori H, Fujimoto M, Yasuda Y, Mears RP, Onitsuka T.

NPJ Schizophr. 2017 Jan 12;3:3. doi: 10.1038/s41537-016-0008-y. eCollection 2017.

17.

Effect of Clozapine on DNA Methylation in Peripheral Leukocytes from Patients with Treatment-Resistant Schizophrenia.

Kinoshita M, Numata S, Tajima A, Yamamori H, Yasuda Y, Fujimoto M, Watanabe S, Umehara H, Shimodera S, Nakazawa T, Kikuchi M, Nakaya A, Hashimoto H, Imoto I, Hashimoto R, Ohmori T.

Int J Mol Sci. 2017 Mar 14;18(3). pii: E632. doi: 10.3390/ijms18030632.

18.

Differential gene expression profiles in neurons generated from lymphoblastoid B-cell line-derived iPS cells from monozygotic twin cases with treatment-resistant schizophrenia and discordant responses to clozapine.

Nakazawa T, Kikuchi M, Ishikawa M, Yamamori H, Nagayasu K, Matsumoto T, Fujimoto M, Yasuda Y, Fujiwara M, Okada S, Matsumura K, Kasai A, Hayata-Takano A, Shintani N, Numata S, Takuma K, Akamatsu W, Okano H, Nakaya A, Hashimoto H, Hashimoto R.

Schizophr Res. 2017 Mar;181:75-82. doi: 10.1016/j.schres.2016.10.012. Epub 2016 Oct 27.

19.

Transethnic Replication Study to Assess the Association Between Clozapine-Induced Agranulocytosis/Granulocytopenia and Genes at 12p12.2 in a Japanese Population.

Saito T, Ikeda M, Hashimoto R, Iwata N; Members of the Clozapine Pharmacogenomics Consortium of Japan are the following, Yamamori H, Yasuda Y, Fujimoto M, Kondo K, Shimasaki A, Kawase K, Miyata M, Mushiroda T, Ozeki T, Kubo M, Fujita K, Kida N, Nakai M, Otsuru T, Fukuji Y, Murakami M, Mizuno K, Shiratsuchi T, Numata S, Ohmori T, Ueno SI, Yada Y, Tanaka S, Kishi Y, Takaki M, Mamoto A, Taniguchi N, Sawa Y, Watanabe H, Noda T, Amano Y, Kimura T, Fukao T, Suwa T, Murai T, Kubota M, Ueda K, Tabuse H, Kanahara N, Kawai N, Nemoto K, Makinodan M, Nishihata Y, Hashimoto N, Kusumi I, Fujii Y, Miyata R, Hirakawa K, Ozaki N.

Biol Psychiatry. 2017 Jul 1;82(1):e9-e10. doi: 10.1016/j.biopsych.2016.12.009. Epub 2016 Dec 16. No abstract available.

PMID:
28161127
20.

[Merits and Demerits of High-dose Psychotropic Polypharmacy in Schizophrenia from Guidelines].

Hashimoto R, Yasuda Y, Fujimoto M, Yamamori H.

Seishin Shinkeigaku Zasshi. 2017;119(3):185-191. Japanese.

PMID:
30620854

Supplemental Content

Loading ...
Support Center